Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - A follow-up study from the DANBIO Registry

Annals of the Rheumatic Diseases

Volumn 72, Issue 1, 2013, Pages 79-82

  Dreyer, Lene ^a   Mellemkjær, Lene ^b   Andersen, Anne Rødgaard ^c   Bennett, Philip ^d   Poulsen, Uta Engling ^e   Ellingsen, Torkell Juulsgaard ^f   Hansen, Torben Høiland ^g   Jensen, Dorte Vendelbo ^h   Linde, Louise ^c   Lindegaard, Hanne Merete ⁱ   Loft, Anne Gitte Rasmussen ^j   Nordin, Henrik ^k   Omerovic, Emina ^l   Rasmussen, Claus ^m   Schlemmer, Annette ⁿ   Tarp, Ulrik ^o   Hetland, Merete Lund ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f SILKEBORG REGIONAL HOSPITAL   (Denmark)

^g Holbaek University Hospital   (Denmark)

^h Nordsjællands Hospital Hillerød   (Denmark)

ⁱ ODENSE UNIVERSITY HOSPITAL   (Denmark)

^j LILLEBAELT HOSPITAL   (Denmark)

^k Rigshospitalet   (Denmark)

^l KØGE HOSPITAL   (Denmark)

^m NORTH DENMARK REGIONAL HOSPITAL   (Denmark)

ⁿ AALBORG UNIVERSITY HOSPITAL   (Denmark)

^o AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PSORIATIC ARTHRITIS; RECTUM CANCER; RHEUMATOID ARTHRITIS; URINARY TRACT CANCER;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871089931     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201969     Document Type: Article

References (20)

1. Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85. (Pubitemid 43736578)
2. Askling J, Fahrbach K, Nordstrom B, et al. Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 2011;20:119-30.
3. Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95. (Pubitemid 47502734)
4. Strangfeld A, Hierse F, Rau R, et al. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Res Ther 2010;12:R5.
5. Mariette X, Matucci-Cerinic M, Pavelka K, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis 2011;70:1895-904.
6. Geborek P, Bladström A, Turesson C, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with increased risk of lymphomas. Ann Rheum Dis 2005;64:699-703. (Pubitemid 40559295)
7. Askling J, Baecklund E, Granath F, et al. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 2009;68:648-53.
8. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis. The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51. (Pubitemid 38725085)
9. Mariette X, Tubach F, Bagheri H, et al. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis 2010;69:400-8.
10. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
11. Askling J, Fored CM, Brandt L, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1421-6. (Pubitemid 41623851)
12. Setoguchi S, Solomon DH, Weinblatt ME, et al. Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2757-64. (Pubitemid 44497754)
13. Hetland ML. DANBIO-powerful research database and electronic patient record. Rheumatology 2011;50:69-77.
14. Linde L, Sørensen J, Østergaard M, et al. What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire? J Rheumatol 2009;36:2183-9.
15. Mellemkjær L, Linet MS, Gridley G, et al. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996;32A:1753-7. (Pubitemid 26306889)
16. Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum 2011;63:3032-7.
17. Wisgerhof HC, van der Geest LG, de Fijter JW, et al. Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol 2011;35:105-11.
18. Mercer LK, Green AC, Galloway JB, et al. The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2012;71:869-74.
19. Magalhães B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev 2012;21:15-23.
20. Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 2011;104:882-5.